Please assess the completion status of the following clinical trial:

Trial Title: a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. The patient is at least 18 years old~2. The patient is willing and able to comply with the examination schedule and the trial schedule.~3. The patient has suffered from chronic post-surgical neuropathic groin pain for at least 6 months~4. Conservative treatments of the chronic pain including medication, physiotherapy and interventions have been exhausted~5. The pain level at the time of the baseline examination is at least 60mm on the visual analogue scale (VAS) in the primary pain area (groin pain)~6. The patient is able to give consent in writing~Exclusion Criteria:~1. Pregnant or breastfeeding patients or those who plan to become pregnant during the study~2. It has been established in an examination by the tester that the pain has significantly worsened or changed its characteristics in the course of the previous month.~3. In the last 30 days, the patient has been treated with corticosteroids on an area scheduled for the stimulation.~4. In the last 3 months, the patient has been treated with radio frequency therapy on an area scheduled for the stimulation.~5. The patient has already been treated with an active implantable device, including an implantable cardioverter defibrillator, pacemaker, spinal cord stimulator or an intrathecal medication pump.~6. The patient is not able to operate the stimulation device~7. The patient is currently suffering from an infection~8. The patient has participated in another clinical study in the last 30 days~9. The patient has a coagulation disorder or is taking anti-coagulants, which would make participation impossible, as per the study doctor~10. The patient has been diagnosed with a malignancy in the past 2 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treated subjects (Type: None): All subjects recruited and treated with the Axium neurostimulator

Based on this trial design, predict the completion outcome and termination type (if applicable).